What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Identify scenarios where active funds may outperform, focusing on market environments, fees, and your risk tolerance.
14,378 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
A major hedge fund just sold its entire Abercrombie & Fitch stake. Here’s what that means for investors, how to inter...
A major investment advisor just boosted its stake in the Invesco BulletShares 2027 Corporate Bond ETF by about $76 mi...
A leading investment fund recently opened a sizable stake in STGW after marquee client wins. Here’s what this move co...
A major hedge fund recently sold a sizable LASR stake, sparking questions about the stock's future. This article brea...
A big trade in a technology-focused ETF last quarter offers more than a headline. This article digs into what investo...
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
Managed futures ETFs offer a path to diversification when risks rise across markets. This guide explains how they wor...
Small-cap value stocks offer a different path to growth and income. This guide compares ISCV and VBR to help you deci...
Looking for passive income that can edge toward 8% annual returns? This guide covers seven loan-based options, how th...
A startling clip dubbed the horn island video show has sparked discussions about safety and money on trips. This guid...
Franklin Templeton’s tokenization journey marks a turning point for traditional asset managers. This article breaks d...